DAVID L. BARKER - 07 Jul 2022 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role
Director
Signature
/s/ R. Erik Holmlin, Attorney-in-Fact
Issuer symbol
BNGO
Transactions as of
07 Jul 2022
Net transactions value
+$22,680
Form type
4
Filing time
11 Jul 2022, 16:51:12 UTC
Previous filing
13 Jun 2022
Next filing
26 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNGO Common Stock Options Exercise $22,680 +44,470 +320% $0.5100 58,364 07 Jul 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNGO Stock Option (Right to Buy) Options Exercise $0 -44,470 -100% $0.000000* 0 07 Jul 2022 Common Stock 44,470 $0.5100 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vested in equal monthly installments over a one year period such that the option became fully vested on June 30, 2021, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan).
F2 The acquisition of the reported option was reported in a Form 4 filed on July 2, 2020, which mistakenly reported the expiration date as 06/30/2029.